LQDA.NASDAQLiquidia CORP

Form 4: Liquidia Executive Sells Shares

Sentiment:

Insider Transaction (Form 4)


Rajeev Saggar, Chief Medical Officer of Liquidia Corp, sold 79,534 shares of common stock on August 17, 2026.

Summary

  • Open-market sale: disposed of 29,534 Common Stock at $76.84 ($2,269,381) on August 17, 2026; holds 142,265 after (Direct).
  • Option exercise/conversion: acquired 50,000 Common Stock at $3.73 ($186,500) on August 19, 2026; holds 192,265 after (Direct).
  • Open-market sale: disposed of 50,000 Common Stock at $74.06 ($3,702,825) on August 19, 2026; holds 142,265 after (Direct).
  • Option exercise/conversion: disposed of 50,000 Non-Qualified Stock Option (right to buy) on August 19, 2026; holds 150,000 after (Direct).

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $5,972,206 of stock on the open market.

Insider Transactions

Rajeev Saggar — Officer (Chief Medical Officer)

DateTransactionSecuritySharesPriceValueHeld After
2026-08-17Open-market saleCommon Stock29,534$77$2.3M142,265
2026-08-19Option exercise/conversionCommon Stock50,000$4$186.5K192,265
2026-08-19Open-market saleCommon Stock50,000$74$3.7M142,265
2026-08-19Option exercise/conversionNon-Qualified Stock Option (right to buy)50,000——150,000

Key Dates

DateDescription
2026-08-17Open-market sale (29,534 shares)
2026-08-19Option exercise/conversion (50,000 shares)
2026-08-19Open-market sale (50,000 shares)
2026-08-19Option exercise/conversion (50,000 shares)

Keywords

insider transaction, Form 4, LQDA, Liquidia Corp, bearish, Rajeev Saggar

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.